Health

UK: Boris Johnson set to axe free lateral tests amidst cost concerns

UK: Boris Johnson set to axe free lateral tests amidst cost concerns

Health

Boris Johnson, the UK’s Prime Minister, has reportedly proposed to scrap the free lateral flow tests to curb cost concerns. Free testing will be confined to high-risk locations such as hospitals, nursing homes, and schools under the revised guidelines.

As per a senior Whitehall official, it is possibly not the right time to send out free lateral flow tests to everyone. Most likely, the government is going to shift to less testing and will be able to ramp it up if found necessary.

Recently, Nicola Sturgeon warned Prime Minister Johnson that eliminating the free tests would be completely wrongheaded.

Read More

India to administer COVID booster shots to frontline workers, elders

India to administer COVID booster shots to frontline workers, elders

Health

Indian Prime Minister, Narendra Modi, in a national TV address, has reportedly announced that starting January 10th 2022, the government will start giving out COVID-19 booster shots to healthcare workers and other frontline workers as a precautionary measure amidst growing cases of Omicron variants in the country.

Modi also added that the booster doses would also be made available for those above the age of 60 with comorbidities, following a recommendation from doctors.

Along with the booster shots, the COVID-19 vaccination drive for those aged between 15 and 18 will also begin from January 3rd 2022.

Advarra launches next-gen cloud platform for clinical trial processes

Advarra launches next-gen cloud platform for clinical trial processes

Health

Advarra Inc., a leading US-based company providing clinical research solutions and services, has announced the launch of Advarra Cloud, a next-generation cloud platform.

With Advarra Cloud, customers will be offered a wider range of options for cloud deployment and will have applications delivered in an easy-to-use and fully managed environment, while also being provided with pre-validated installation and operational qualification.

The platform has been built upon the best industry practices with reduced complexity and an overall lower cost and comes with an architecture that can keep up with the changing regulatory compliance and busi

Aurobindo, Unichem recall products due to manufacturing issues in US

Aurobindo, Unichem recall products due to manufacturing issues in US

Health

US-based units of Indian pharmaceutical companies, Unichem Laboratories and Aurobindo Pharma, have ordered a nationwide recall of different products in the regional market, citing manufacturing issues.

As per sources, Aurobindo Pharma USA Inc. has recalled 7,296 containers of its hypertension drug tablets, Carvedilol, following the recently issued enforcement report by the US Food and Drug Administration (USFDA).

Carvedilol, a beta-blocker, is used in the treatment of high blood pressure to prevent the chances of stroke, heart attack, or kidney problems. 

The affected lot of 6.25 mg of Carvedilo

Merck’s Covid pill suggested by FDA advisory panel for emergency use

Merck’s Covid pill suggested by FDA advisory panel for emergency use

Health

Merck's novel antiviral pill to cure Covid-19 was suggested for emergency use approval by a Food and Drug Administration (FDA) advisory panel, clearing the path for the government to approve the very first oral medicines for treating Covid.

The drug, known as molnupiravir, was voted by the agency's Antimicrobial Drugs Advisory Committee (AMDAC) for treating people with chronic to moderate Covid-19 who are at risk of serious disease or hospitalization.

Prior to voting in favor of the medicine, members of the committee posed various questions as well as voiced concerns about its efficacy and safety during the daylong community mee

AbbaDox, Zadara Edge Cloud partner to offer PACS-as-a-Service

AbbaDox, Zadara Edge Cloud partner to offer PACS-as-a-Service

Health

Edge cloud services provider, Zadara has teamed up with AbbaDox, one of the largest suppliers of cloud-based radiology information SaaS solutions, to provide a complete PACS-as-a-Service with unlimited platform-edge computational capacity, low-latency network connectivity, as well as storage.

This on-demand service adds to AbbaDox's existing technology stack ecosystem, providing imaging centers as well as radiology providers with cost-effective options to be profitable and competitive in an ever-changing industry.

Imaging providers are leading the way in the implementation of cloud technologies in healthcare by streamlining back-off

NCSC: UK cyberattacks hit new record, targeting COVID vaccine research

NCSC: UK cyberattacks hit new record, targeting COVID vaccine research

Health

The National Cyber Security Centre, a cybersecurity guidance and support agency of the UK government, also known as NCSC, has reportedly stated that Britain had to address a record 777 incidents of cyberattacks over the course of the past year, with COVID-19 vaccine research being the prime target for these attacks.

According to reports, the NCSC, which is a part of the UK Government Communications Headquarters (GCHQ), stated that several of the supposed attacks were traced back to hostile states, including China and Russia.

The incidents also included a vast global hacking campaign, which has been blamed on the foreign intelligence ser

DrugStoc secures $4.4M Series A funding to further expand in Nigeria

DrugStoc secures $4.4M Series A funding to further expand in Nigeria

Health

DrugStoc, a Nigerian startup dealing with e-health pharmaceutical distribution, has reportedly closed a $4.4 million Series A funding round. With the investment, the firm aims to aggressively expand in the country to deliver pharmaceutical products to around 100 million people.

As it advances outside Lagos, the West African country's economic core, the firm intends to expand into 16 new states across Nigeria. The strategy aligns with its more ambitious goal of foraying outside Nigeria and into other African markets.

It is reported that within Nigeria, ready accessibility to pharmaceutical products can avert thousands of easily preve

Israel to announce impending decision on approving Pfizer for children

Israel to announce impending decision on approving Pfizer for children

Health

During a recent cabinet meeting, Naftali Bennett, the Prime Minister of Israel, reportedly stated that Israel is looking into data on Pfizer's new corona medicine and the issue of securing its supplies for the nation’s population.

Meanwhile, the country’s Ministry of Health also announced that a decision on whether or not to approve the COVID-19 vaccination for children, aged between 5 to 11, will be unveiled on Wednesday.

Addressing the same, PM Bennett stated that there might be positive news concerning a cure for COVID-19. Over the weekend, the PM has asked the system to do an in-depth study of the purported new drug